DARE BIOSCIENCE, INC. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/01041815-43b8-49e6-90b7-1ed6d49f8be2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-13.6M | 2025-01-01 – 2025-12-31 | evidence 0001401914-26-000004 |
| FY 2024 | $-23.5M | 2024-01-01 – 2024-12-31 | evidence 0001401914-25-000012 |
| FY 2023 | $-30.9M | 2023-01-01 – 2023-12-31 | evidence 0001401914-24-000016 |
| FY 2022 | $-31.4M | 2022-01-01 – 2022-12-31 | evidence 0001401914-23-000013 |
| FY 2021 | $-39.1M | 2021-01-01 – 2021-12-31 | evidence 0001401914-22-000032 |
| FY 2020 | $-27.4M | 2020-01-01 – 2020-12-31 | evidence 0001401914-21-000041 |
| FY 2019 | $-14.3M | 2019-01-01 – 2019-12-31 | evidence 0001401914-20-000042 |
| FY 2018 | $-16.9M | 2018-01-01 – 2018-12-31 | evidence 0001401914-19-000015 |
| FY 2017 | $-11.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006989 |
| FY 2016 | $-630.6k | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-006989 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).